4//SEC Filing
Devroe Eric 4
Accession 0000905148-25-000834
CIK 0001781174other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:21 PM ET
Size
5.2 KB
Accession
0000905148-25-000834
Insider Transaction Report
Form 4
Devroe Eric
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-03-01+140,540→ 140,540 totalExercise: $5.31Exp: 2035-02-28→ Common Stock (140,540 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest on March 1, 2026, and the remaining shares subject to the option vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each vesting date.
Documents
Issuer
Acrivon Therapeutics, Inc.
CIK 0001781174
Entity typeother
Related Parties
1- filerCIK 0001950573
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:21 PM ET
- Size
- 5.2 KB